This tender seeks proposals for the placement of an Early Infant Diagnosis Screening Assay for HIV Nucleic Acid Qualitative Detection, including service and maintenance for three years across NHLS laboratories.
The National Health Laboratory Service (NHLS) invites bids for the placement of an Early Infant Diagnosis Screening Assay aimed at enhancing the detection of HIV in infants. This project is critical in the fight against mother-to-child transmission of HIV, requiring a molecular assay capable of detecting low viral loads in infants. The successful bidder will be responsible for providing the assay, which must meet stringent technical specifications, including sensitivity and specificity requirements, and must be supported by a comprehensive service and maintenance plan over a three-year period.
Bidders are expected to demonstrate their capability to deliver the assay to NHLS laboratories nationwide, ensuring compliance with Department of Health guidelines. The contract will also require the provision of training and technical support to laboratory personnel, as well as the supply of necessary reagents and consumables. This initiative not only aims to improve health outcomes for infants but also seeks to bolster the overall capacity of the NHLS in managing HIV diagnostics effectively.
This tender is suitable for businesses specializing in medical diagnostics, particularly those with experience in HIV testing technologies and laboratory services. Companies that can provide comprehensive support, including training and maintenance, are encouraged to apply.